PHANES THERAPEUTICS
Live / Registered — Registered (as of 25 Apr 2023)
What this means for you
Registered since 25 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90553305
- Registration number
- 7037727
- Mark type
- Design + words
- Filed
- 01 Mar 2021
- Published for opposition
- 06 Jul 2021
- Registered
- 25 Apr 2023
- Attorney of record
- Matthew R. Grothouse
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for oncological related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; Medical preparations for the treatment of oncological related diseases and disorders; Tumor suppressing agents; Clinical medical reagents; Anti-cancer preparations; Cellular function activating agents for medical purposes
Owner
- Phanes Therapeutics, Inc., San Diego, CA, US
- Phanes Therapeutics, Inc., San Diego, CA, US
- Phanes Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 25 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 24 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Mar 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Feb 2023 — USE AMENDMENT FILED
- 04 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Feb 2023 — TEAS STATEMENT OF USE RECEIVED
- 26 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Aug 2022 — SOU EXTENSION 2 GRANTED
- 24 Aug 2022 — SOU EXTENSION 2 FILED
- 24 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 18 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2022 — SOU EXTENSION 1 GRANTED
- 16 Feb 2022 — SOU EXTENSION 1 FILED